Anger :: Intense anger is associated with potentially fatal arrhythmias
Acute episodes of anger may cause potentially fatal heart rhythm disturbances, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Acute episodes of anger may cause potentially fatal heart rhythm disturbances, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Children with risk factors such as high blood pressure, obesity, diabetes and high cholesterol levels already show signs of fatty build-up in their arteries that could lead to heart attack in adulthood, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Hershey Canada Inc. has voluntarily recalled a wide range of chocolate products nationwide and closed its Smiths Falls plant after salmonella bacteria was detected in the candy produced there.
Millions of seniors are once again affected with the issue of Medicare Part D, with the new enrollment period for the prescription drug plan starting Wednesday and running through Dec. 31.
A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease.
New data show that in cases of out-of-hospital cardiac arrest, interrupting chest compressions for anything — including mouth-to-mouth ventilations — appears to be detrimental. Cardiocerebral Resuscitation, a new, chest-compression-only approach developed at the University of Arizona Sarver Heart Center, improved survival rates by 300 percent and enhances bystanders’ willingness to perform CPR.
Human papillomaviruses (HPV) are the most common sexually transmitted infections in the United States, and certain “high risk” types have been shown to cause cervical cancer. Despite recent advances in the detection and prevention of HPV, the link between the virus and cervical cancer is not well known to the public.
Women with systemic lupus who become pregnant are at significantly greater risk for death or other medical complications than are pregnant women without lupus, Duke University Medical Center researchers have found in a nationwide study of more than 18 million women.
Data presented at this year’s American College of Rheumatology Congress (ACR) show that patients receiving repeat treatment with MabThera/Rituxan (rituximab) achieved continued improvement in both physical and mental aspects of quality of life measures. In addition, a higher proportion of patients achieved a significant improvement in disease symptoms with a second course of MabThera, compared to the first course they received.
Magnetic resonance spectroscopy may provide a noninvasive way to monitor neuropsychiatric symptoms in patients with lupus, according to results from research in mice at Wake Forest University School of Medicine.